BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Initial Results Of Leiner Health Products Inc. Funded Study Reveal Glucosamine And Chondroitin Effective In Treating Moderate To Severe Osteoarthritis Knee Pain


11/10/2005 11:37:03 AM

CARSON, Calif., Nov. 10 /PRNewswire/ -- For 21 million Americans hobbled by osteoarthritis, new science confirms nutritional supplements glucosamine and chondroitin are the right combination for effective knee pain relief(1). The Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT), funded by NIH, rigorously evaluated the efficacy and safety of glucosamine and chondroitin in 1,258 people, concluding in its abstract that the "combination of glucosamine and chondroitin sulfate is effective in treating moderate to severe knee pain due to osteoarthritis."

GAIT lead researcher Daniel O. Clegg, M.D., Professor of Medicine and Chief of Rheumatology at the University of Utah, will present findings from the full study on November 14, 2005 at the American College of Rheumatology's Scientific Meeting in San Diego, California.

"GAIT brings good news to adults suffering from the wear and tear of cartilage degeneration, particularly those who cannot tolerate the side effects of taking nonsteroidal anti-inflammatory drugs (NSAIDs)," said C. Thomas Vangsness, Jr., MD, Professor Orthopaedic Surgery, Keck School of Medicine, University of Southern California. "For years glucosamine and chondroitin have been well recognized alternative solutions to pharmaceutical options in treating osteoarthritis patients in Europe, Asia and Russia. In fact, preliminary results reported in the GAIT abstract indicated glucosamine and chondroitin were found to be more effective than Celebrex(R) in treating moderate to severe knee pain. Clearly, the GAIT abstract suggests glucosamine and chondroitin together may be a good non-surgical pain relief choice for arthritis patients," added Dr. Vangsness.

Funded by NIH, the $14 million GAIT study is the largest placebo controlled, double blind, clinical trial ever conducted to test the effectiveness of glucosamine and chondroitin. All 1,258 patients who completed the study were over the age of 40 with knee pain and randomly assigned placebo; glucosamine 1500 mg; chondroitin 1200mg; glucosamine/chondroitin at above mentioned doses; or celecoxib (Celebrex) 200 mg daily for 6 months. The abstract published each treatment group's response rate to pain. Of note, the group taking the glucosamine/chondroitin combination experienced greater relief for the treatment of moderate to severe knee pain than the Celebrex group.

GAIT was designed to test the safety and efficacy of glucosamine and chondroitin alone and in combination in reducing knee pain associated with osteoarthritis. The study's abstract concluded that when taken together, "glucosamine and chondroitin is effective in treating moderate to severe knee pain due to OA [osteoarthritis]."

Naturally occurring in the body, glucosamine stimulates the production of cartilage, the connective tissue which cushions joints. Chondroitin is also naturally occurring in the body and like glucosamine stimulates the production of cartilage. Previous research indicates glucosamine is just as effective as non-steroidal anti-inflammatory drugs (NSAIDs) in reducing osteoarthritis pain and has fewer gastrointestinal side effects than NSAIDs.

Store brand nutritional supplements offer consumers the highest quality product at the best value. On average, double strength glucosamine(500mg)/chondroitin(400mg) sells for 35% less than brand name double strength glucosamine/chondroitin products and triple strength glucosamine (750mg)/chondroitin (600mg) sells for about 15% less than higher priced brands. Consumers can find store brand glucosamine and chondroitin products at the nation's leading retailers.

Nearly 1 in 3 Americans (nearly 70 million) live with some form of arthritis, costing the United States $82.5 billion a year in healthcare costs related to treating the illness.(2) For arthritis knee pain sufferers who find relief in taking glucosamine and chondroitin, they will also find the supplements to be great values. Widely used in Europe for years to treat osteoarthritis, glucosamine and chondroitin are safe and effective nutritional supplements, as proven by the GAIT abstract.

To find the full GAIT abstract visit http://www.rheumatology.org/annual/abstracts/search.asp

About Leiner Health Products (http://www.leiner.com)

Founded in 1973, Leiner Health Products, headquartered in Carson, California, is America's largest manufacturer of store brand vitamins, minerals, and supplements. The company also is a leading store brand supplier in the rapidly growing over-the-counter (OTC) pharmaceutical market. Selling products exclusively to the nation's leading retailers, Leiner provides nearly 40 food, drug, mass, club and dollar store merchants with over 3,000 products, creating extraordinary, high quality store brands at a great value. Leiner markets a full line of vitamins, minerals and supplements under its YourLife(R) brand, which is the leading brand worldwide in the US military. The company also markets over-the-counter drugs under its Pharmacist's Formula(R) brand. In 2004, Leiner produced 29 billion doses.

(1) American Arthritis Foundation

(2) American College of Rheumatology

Leiner Health Products

CONTACT: Crystal Wright of Leiner Health Products, +1-202-291-8481



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->